SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
8294692
Source:
http://linkedlifedata.com/resource/pubmed/id/8294692
Search
Subject
(
42
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0001443
,
umls-concept:C0011923
,
umls-concept:C0012582
,
umls-concept:C0038435
,
umls-concept:C0042402
,
umls-concept:C1522564
pubmed:issue
2
pubmed:dateCreated
1994-2-25
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/8294692-8294691
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8301365
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Adenosine
,
http://linkedlifedata.com/resource/pubmed/chemical/Dipyridamole
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0735-1097
pubmed:author
pubmed-author:LabovitzA JAJ
,
pubmed-author:MillerD DDD
pubmed:issnType
Print
pubmed:volume
23
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
390-2
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:8294692-Adenosine
,
pubmed-meshheading:8294692-Coronary Disease
,
pubmed-meshheading:8294692-Dipyridamole
,
pubmed-meshheading:8294692-Heart
,
pubmed-meshheading:8294692-Heart Block
,
pubmed-meshheading:8294692-Humans
,
pubmed-meshheading:8294692-Registries
,
pubmed-meshheading:8294692-Risk Factors
,
pubmed-meshheading:8294692-Safety
pubmed:year
1994
pubmed:articleTitle
Dipyridamole and adenosine vasodilator stress for myocardial imaging: vive la différence!
pubmed:publicationType
Clinical Trial
,
Editorial
,
Comment
,
Multicenter Study
,
Clinical Trial, Phase III